- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Health Care & Insurance
Life sciences finance pro heading to startup
November 10, 2012
Chris O'MalleyIf a biotech startup were akin to a rock band, Kristin Sherman might be the keyboardist. She’s not front-and-center
on the stage, but the ballad wouldn’t be as dynamic without her pounding the chords.
MoreIndiana's top state budget official finds new job
November 9, 2012
Associated PressThe top state budget official under Indiana Gov. Mitch Daniels has decided to move into an executive position with Indiana
University Health when the governor's term ends in January.
MoreHealth insurance stocks flop after Obama wins second term
November 8, 2012
Associated PressHealth insurance stocks sank deeper than the broader market Wednesday after President Barack Obama's re-election helped
clarify the future of his health care overhaul, a sweeping law that some investors fear will pinch profits.
MoreWellPoint shares droop despite profitable quarter
November 7, 2012
Bloomberg NewsWellPoint Inc.'s third-quarter earnings trumped Wall Street expectations, but the health insurer's stock tumbled Wednesday
after President Barack Obama won re-election, a victory that could help cement the future of his health care overhaul.
MoreDeal provides peek at Anthem's narrow networks
November 5, 2012
J.K. WallA new agreement in Wisconsin provides a glimpse of the kind of “narrow network” arrangements that Indianapolis-based
Anthem Blue Cross and Blue Shield might attempt in Indiana.
MoreCommunity to commercialize innovations
November 5, 2012
J.K. WallCommunity Health Network thinks it can help patients, engage doctors and maybe even make some money by trying to turn ideas
within its organization into commercial products, service and companies.
MoreLife sciences leader juggles faith, science and business
November 3, 2012
J.K. WallBioCrossroads CEO David Johnson sees little conflict as he balances all three in promoting and investing in Indiana life sciences
firms
MoreLow enrollment clouds Healthy Indiana Plan
November 3, 2012
J.K. WallMany Indiana Republicans want to use the Healthy Indiana Plan to expand Medicaid coverage in Indiana to more low-income adults.
But the program—which offers health insurance based on health savings accounts to uninsured adults—has managed
to attract just one-third of the Hoosiers it was designed for and has cost about twice as much per enrollee as predicted.
MoreLilly to spend $140M on new insulin cartridge plant
November 1, 2012
J.K. WallAbout 100 workers will staff the new plant, which will be constructed by spring 2014 and ready for operations in 2015. But
only “some” of that number will be new hires.
MoreLilly plans expansion of local insulin plant
October 30, 2012
J.K. WallThe Indianapolis-based drugmaker plans to expand its local insulin plants to make insulin cartridges to meet what it describes
as growing demand in the United States.
MoreLilly's Cialis receives European approval for new use
October 30, 2012
Associated PressThe European Union has approved Eli Lilly and Co.'s erectile dysfunction drug Cialis to treat symptoms tied to an enlarged
prostate.
MoreColts QB Luck, Riley Hospital reach multiyear promotional deal
October 30, 2012
Anthony SchoettleIndianapolis Colts rookie quarterback Andrew Luck on Tuesday will announce his first local sponsorship deal, a four-year pact
with Riley Hospital for Children at Indiana University Health.
MoreCNO Financial earnings fall on recapitalization charge
October 29, 2012
IBJ StaffCarmel-based CNO Financial Group on Monday reported a third-quarter loss of $5 million compared to a $179.5 million profit
in the third quarter of 2011.
MoreLilly's insulin dip concerns analysts
October 29, 2012
J.K. WallEli Lilly and Co. suffered a tough week on the stock market, in part because of a disturbing bit of news buried in its third-quarter
earnings report: Lilly’s insulin sales are down.
MoreOutlook gloomy for device investments
October 29, 2012
J.K. WallThe amount of venture capital invested in medical-device and equipment companies nationally has declined each quarter this
year, reaching levels not seen since 2004, according to data released Oct. 19 by the National Venture Capital Association
and PricewaterhouseCoopers.
MoreJudge approves $90 million for Anthem plaintiffs
October 29, 2012
Kathleen McLaughlinThe settlement will go to 700,000 claimants in Indiana, Ohio, Kentucky and Connecticut, who said Anthem underpaid them when
it converted in 2001 from policyholder ownership into publicly traded company WellPoint Inc.
MoreZimmer trims full-year forecast after quarterly profit falls
October 25, 2012
J.K. WallThe Warsaw-based maker of orthopedic implants beat analysts’ estimates with its third-quarter earnings, but lowered
its full-year forecast.
MoreLilly misses analyst estimates, lowers profit forecast
October 24, 2012
J.K. WallThird-quarter earnings at Eli Lilly and Co. fell short of analysts' expectations, and the Indianapolis-based drugmaker reduced
its profit forecast by 4 cents per share for the remainder of the year.
MoreAmerigroup shareholders approve $4.9B sale to WellPoint
October 24, 2012
J.K. WallShareholders of Amerigroup Corp. overwhelming approved the Virginia company’s sale for $4.9 billion to Indianapolis-based
health insurer WellPoint Inc. in a vote on Tuesday. The vote clears the way for the acquisition to close before the end of
the year.
MoreLilly CEO calls for life sciences research institute
October 23, 2012
J.K. WallEli Lilly CEO John Lechleiter on Tuesday called for creation of a "world-class" research institute in Indianapolis to bring
together scientists from universities and corporations to develop new medical therapies and companies.
MoreRoche continues to restructure diabetes unit
October 22, 2012
J.K. WallRoche officials said last week that price competition and lower reimbursement rates are forcing it to make an unspecified
number of cuts in its U.S. sales force and at its research and development hubs in Indianapolis and Germany.
MoreLilly continues string of positive trials
October 22, 2012
J.K. WallEli Lilly and Co. is continuing a string of positive yet incomplete clinical trial results, giving it a boost among investors.
MoreLilly says experimental diabetes drug outperformed rivals
October 22, 2012
J.K. WallEli Lilly and Co. said dulaglutide lowered blood sugar better than three existing diabetes drugs in three Phase 3 clinical
trials. Analysts expect the drug to hit the market in 2014 or 2015 and become a blockbuster.
MoreIndianapolis tech firms, hospitals discover mutual need
October 20, 2012
Chris O'MalleyAn initiative is matching tech entrepreneurs with hospital officials in the hope of solving health care problems.
MoreAlzheimer’s prevention seen promising as drug cures fail
October 19, 2012
Bloomberg NewsResearchers are set to test drugs by Eli Lilly and other companies that may prevent Alzheimer’s disease after efforts
to find a cure have been unsuccessful.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
See, I told u Indyman and Dipsicle....this 8 days is overkill. It's barely worth a weekend....great job Tony George! Your dream has been fulfilled....he fans want the I r l back. Thats how good it was.....and that sucked.
I have been in training for a short time now but right off I can see that safety and quality are the number one issues, my experience as of late has been a positive one, the employees along with Jeff the plant manager and the operation supervisor as well as the engineers are a highly motivated group of people, what an asset for the area to have and for company's in need of a quality metal products.
Pimlico
While I understand the severity of their actions as well as everyones eagerness to hold them responsible for thier lost funds, these gentlemen did know how to make money. Dispite thier poor decisions over the ownership of Fair they had made several wise investments which paid them greatly. This proves they do have the potential to rebuild so they can repay. I do not feel they should live the life of luxuary but given an opportunity could they find ways of repaying the debts? They are doing nothing now but being a burden on tax payers. Just a thought!!!!!
You guys have some "interesting" comments to say the least. I hope you will call in and share those opinions starting June 1. I'm looking forward to having you on the air.